Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriella Pietra

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Current Opinion in Immunology|May 12, 2005
Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptorsMaria Cristina Mingari, Gabriella Pietra, Lorenzo Moretta
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
TIGIT Blockade and IL15 in Tumor Immunotherapy: Together is BetterGabriella Pietra, Maria Cristina Mingari, Lorenzo Moretta
Trends in Immunology|January 6, 2019
Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on BoardMaria Cristina Mingari, Gabriella Pietra, Lorenzo Moretta
Oncoimmunology|November 20, 2012
How melanoma cells inactivate NK cellsGabriella Pietra, Massimo Vitale, Lorenzo Moretta, et al.
Current Pharmaceutical Design|October 29, 2009
HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cellsGabriella Pietra, Chiara Romagnani, Lorenzo Moretta, et al.
Journal of Biomedicine & Biotechnology|July 17, 2010
The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumorsGabriella Pietra, Chiara Romagnani, Claudia Manzini, et al.
Trends in Immunology|March 5, 2003
NK-CTLs, a novel HLA-E-restricted T-cell subsetLorenzo Moretta, Chiara Romagnani, Gabriella Pietra, et al.
Cancers|March 29, 2020
Targeted Therapies: Friends or Foes for Patient's NK Cell-Mediated Tumor Immune-Surveillance?Laura Damele, Selene Ottonello, Maria Cristina Mingari, et al.
European Journal of Immunology|April 30, 2014
Effect of tumor cells and tumor microenvironment on NK-cell functionMassimo Vitale, Claudia Cantoni, Gabriella Pietra, et al.
Frontiers in Immunology|December 1, 2025
Editorial: Cytokines, and biomarkers involved in the immunomodulation of pediatric cancersAlessandro Poggi, Gabriella Pietra, Ignazio Caruana, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Opinion in Immunology|May 12, 2005
Human cytolytic T lymphocytes expressing HLA class-I-specific inhibitory receptorsMaria Cristina Mingari, Gabriella Pietra, Lorenzo Moretta
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
TIGIT Blockade and IL15 in Tumor Immunotherapy: Together is BetterGabriella Pietra, Maria Cristina Mingari, Lorenzo Moretta
Trends in Immunology|January 6, 2019
Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on BoardMaria Cristina Mingari, Gabriella Pietra, Lorenzo Moretta
Oncoimmunology|November 20, 2012
How melanoma cells inactivate NK cellsGabriella Pietra, Massimo Vitale, Lorenzo Moretta, et al.
Current Pharmaceutical Design|October 29, 2009
HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cellsGabriella Pietra, Chiara Romagnani, Lorenzo Moretta, et al.
Journal of Biomedicine & Biotechnology|July 17, 2010
The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumorsGabriella Pietra, Chiara Romagnani, Claudia Manzini, et al.
Trends in Immunology|March 5, 2003
NK-CTLs, a novel HLA-E-restricted T-cell subsetLorenzo Moretta, Chiara Romagnani, Gabriella Pietra, et al.
Cancers|March 29, 2020
Targeted Therapies: Friends or Foes for Patient's NK Cell-Mediated Tumor Immune-Surveillance?Laura Damele, Selene Ottonello, Maria Cristina Mingari, et al.
European Journal of Immunology|April 30, 2014
Effect of tumor cells and tumor microenvironment on NK-cell functionMassimo Vitale, Claudia Cantoni, Gabriella Pietra, et al.
Frontiers in Immunology|December 1, 2025
Editorial: Cytokines, and biomarkers involved in the immunomodulation of pediatric cancersAlessandro Poggi, Gabriella Pietra, Ignazio Caruana, et al.
Pageof 6